CIK 0001211583 · Non-accelerated filer<br>Smaller reporting company
FENNEC PHARMACEUTICALS INC.
Sign in to watch- Ticker
- FENC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (919) 636-4530
- Business address
- PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK, NC, 27709
- Former names
- ADHEREX TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,310,718
- in 4 filings, $1.2M under 10b5-1 plans
Net −$1,310,718. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-07 | Southpoint Capital Advisors LP 10% owner | Sale | −26,900 | $9.59 | $258K | 4,050,314 |
| 2025-10-06 | Raykov Rosty Director | Sale 10b5-1 | −10,000 | $9.78 | $98K | 82,501 |
| 2025-09-30 | Raykov Rosty Director | Grant or award | +5,208 | 92,501 | ||
| 2025-09-30 | Andrade Robert CHIEF FINANCIAL OFFICER | Grant or award | +2,430 | 170,674 | ||
| 2025-09-05 | Raykov Rosty Director | Option exercise | +36,207 | $2.45 | $89K | 87,293 |
| 2025-09-05 | Raykov Rosty Director | Option exercise · Stock Options | −36,207 | $2.45 | $89K | 1,638,793 |
| 2025-09-04 | Raykov Rosty Director | Sale 10b5-1 | −10,000 | $8.92 | $89K | 51,086 |
| 2025-08-31 | Andrade Robert CHIEF FINANCIAL OFFICER | Grant or award | +2,431 | 168,244 | ||
| 2025-08-31 | Raykov Rosty Director | Grant or award | +5,208 | 61,086 | ||
| 2025-08-05 | Raykov Rosty Director | Sale 10b5-1 | −10,000 | $8.09 | $81K | 55,878 |
| 2025-07-31 | Raykov Rosty Director | Grant or award | +5,208 | 65,878 | ||
| 2025-07-31 | Andrade Robert CHIEF FINANCIAL OFFICER | Grant or award | +2,431 | 165,813 | ||
| 2025-07-07 | RALLIS CHRIS A Director | Option exercise 10b5-1 | +2,127 | $2.35 | $5K | 55,911 |
| 2025-07-07 | RALLIS CHRIS A Director | Sale 10b5-1 | −1,119 | $8.71 | $10K | 54,792 |
| 2025-07-07 | RALLIS CHRIS A Director | Option exercise · Common Shares 10b5-1 | −2,127 | $2.35 | $5K | 178,406 |
| 2025-07-03 | Raykov Rosty Director | Sale 10b5-1 | −10,000 | $8.61 | $86K | 60,670 |
| 2025-06-30 | Raykov Rosty Director | Grant or award | +5,208 | 70,670 | ||
| 2025-06-30 | Andrade Robert CHIEF FINANCIAL OFFICER | Grant or award | +2,431 | 163,382 | ||
| 2025-06-05 | Raykov Rosty Director | Sale 10b5-1 | −10,000 | $7.78 | $78K | 65,462 |
Page 8 of 8 · 159 trades